Phase I dose-escalation trial of ONT-380 in combination with trastuzumab in participants with brain metastases from HER2+ breast cancer.
Otto Metzger-Filho
No relevant relationships to disclose
William Thomas Barry
No relevant relationships to disclose
Ian E. Krop
No relevant relationships to disclose
W. Jerry Younger
No relevant relationships to disclose
Elizabeth S Lawler
No relevant relationships to disclose
Eric P. Winer
No relevant relationships to disclose
Nancy U. Lin
No relevant relationships to disclose